RankAlpha logo
Back to Rankings

GELS

GelteqD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
GELS vs peer average
52/100
GELS vs. peer average (D vs. D)
Grade spread
A 1 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ERNA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $6.33M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerERNAErnexa Therapeutics
GELS
Gelteq
ERNA
Ernexa Therapeutics
Grade
D
D
Momentum
50
93
Value
47
58
Sentiment
-
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ERNA

GELS / ERNA
Grade Position
In line
GELS vs. peer average (D vs. D)
52/100
Momentum
50
ERNA
Value
47
ERNA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GELS
1
ERNA
Ernexa Therapeutics Inc Common
D
40/100
Even
2
XTLB
XTL Biopharmaceuticals Ltd ADR
F
20/100
+1
3
XBIO
Xenetic Biosciences Inc Common
A
100/100
-3
4
CVKD
Cadrenal Therapeutics Inc Common
F
20/100
+1
5
PCSA
Processa Pharmaceuticals Inc Common
F
20/100
+1
ERNA is the first peer returned for this comparison set.